Potential of IRMS technology for tracing gamma-butyrolactone (GBL)

François Marclay1, Diego Pazos, Olivier Delémont

  • 1Swiss Laboratory for Doping Analyses, University Centre of Legal Medecine, Geneva and Lausanne, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Ch. des Croisettes 22, Epalinges, Switzerland.

Related Concept Videos